Drug information for DUETACT
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
2MG;30MG
Prescription
(Reference Drug)
GLIMEPIRIDE
;
PIOGLITAZONE HYDROCHLORIDE
glimepiride
TAKEDA GLOBAL
21925
2011-08-04 Other
2011-08-04 Label
2011-08-04 Label
2011-08-04 Letter
2011-08-04 Letter
2011-08-04 Medication Guide
2010-09-29 Label
2010-09-28 Letter
2009-10-26 Letter
2009-10-06 Other
2009-09-18 Medication Guide
2009-01-06 Letter
2009-01-06 Label
2008-09-04 Review
2007-10-04 Label
2007-10-04 Letter
2007-10-04 Letter
2007-09-26 Label
2007-09-11 Letter
2007-09-07 Label
2007-08-15 Other Important Information from FDA
2007-02-23 Label
2007-02-12 Letter
2006-08-04 Letter
2006-08-04 Label
TABLET; ORAL
4MG;30MG
Prescription
GLIMEPIRIDE
;
PIOGLITAZONE HYDROCHLORIDE
glimepiride
TAKEDA GLOBAL
"
Drug Adverse Effects information for DUETACT
Role code
Indications
Reaction
# Reports
PS
TYPE 2 DIABETES MELLITUS
BLADDER CANCER
1
SS
TYPE 2 DIABETES MELLITUS
BLADDER CANCER
2
SS
TYPE 2 DIABETES MELLITUS
BLADDER CANCER STAGE II
2
SS
TYPE 2 DIABETES MELLITUS
NO ADVERSE EVENT
2
C
PRODUCT USED FOR UNKNOWN INDICATION
SKIN CANCER
1
Ads by Google